1. Home
  2. ONC vs IT Comparison

ONC vs IT Comparison

Compare ONC & IT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONC
  • IT
  • Stock Information
  • Founded
  • ONC 2010
  • IT 1979
  • Country
  • ONC Switzerland
  • IT United States
  • Employees
  • ONC N/A
  • IT N/A
  • Industry
  • ONC Biotechnology: Pharmaceutical Preparations
  • IT Other Consumer Services
  • Sector
  • ONC Health Care
  • IT Consumer Discretionary
  • Exchange
  • ONC Nasdaq
  • IT Nasdaq
  • Market Cap
  • ONC 37.3B
  • IT 30.7B
  • IPO Year
  • ONC N/A
  • IT 1993
  • Fundamental
  • Price
  • ONC $330.57
  • IT $249.13
  • Analyst Decision
  • ONC Strong Buy
  • IT Hold
  • Analyst Count
  • ONC 9
  • IT 9
  • Target Price
  • ONC $335.78
  • IT $335.75
  • AVG Volume (30 Days)
  • ONC 365.5K
  • IT 1.4M
  • Earning Date
  • ONC 11-11-2025
  • IT 11-04-2025
  • Dividend Yield
  • ONC N/A
  • IT N/A
  • EPS Growth
  • ONC N/A
  • IT 54.75
  • EPS
  • ONC N/A
  • IT 16.25
  • Revenue
  • ONC $4,562,002,000.00
  • IT $6,420,009,000.00
  • Revenue This Year
  • ONC $875.58
  • IT $6.69
  • Revenue Next Year
  • ONC $20.99
  • IT $4.22
  • P/E Ratio
  • ONC N/A
  • IT $15.22
  • Revenue Growth
  • ONC 47.33
  • IT 5.89
  • 52 Week Low
  • ONC $170.99
  • IT $223.65
  • 52 Week High
  • ONC $351.27
  • IT $584.01
  • Technical
  • Relative Strength Index (RSI)
  • ONC 55.24
  • IT 43.75
  • Support Level
  • ONC $324.03
  • IT $231.33
  • Resistance Level
  • ONC $336.80
  • IT $247.48
  • Average True Range (ATR)
  • ONC 7.92
  • IT 6.34
  • MACD
  • ONC -0.43
  • IT 4.33
  • Stochastic Oscillator
  • ONC 64.85
  • IT 80.41

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.

About IT Gartner Inc.

Gartner Inc provides independent research and analysis on information technology and other related technology industries. Its research is delivered to clients' desktops in the form of reports, briefings, and updates. Typical clients are chief information officers and other business executives who help plan companies' IT budgets. Gartner also provides consulting services. The company operates through three business segments, namely Research, Conferences and Consulting. The company generates majority of the revenue from Research segment.

Share on Social Networks: